Dadun Dadun cabecera universidad cabecera biblioteca
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Inmunología hepatitis virales > DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista >

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity
Authors: Rollier, C.S. (Christine S.)
Paranhos-Baccala, G. (Glaucia)
Verschoor, E.J. (Ernst J.)
Verstrepen, B.E. (Babs E.)
Drexhage, J.A.R. (Joost A.R.)
Fagrouch, Z. (Zahra)
Berland, J.L. (Jean-Luc)
Komurian-Pradel, F. (Florence)
Duverger, B. (Blandine)
Himoudi, N. (Nourredine)
Staib, C. (Caroline)
Meyr, M. (Marcus)
Whelan, M. (Myke)
Whelan, J.A. (Joseph A.)
Adams, V.A. (Victoria A.)
Larrea, E. (Esther)
Riezu-Boj, J.I. (José Ignacio)
Lasarte, J.J. (Juan José)
Bartosch, B. (Birke)
Cosset, F. L. (Francoise-L.)
Spaan, W.J.M. (Willy J.M.)
Diepolder, H.M. (Helmut M.)
Pape, G.R. (Gerd R.)
Sutter, G. (Gerd)
Inchauspe, G. (Geneviese)
Heeney, J.L. (Jonathan L.)
Keywords: Antigens, CD/metabolism
Hepatitis C/immunology
Viral Hepatitis Vaccines/therapeutic use
Issue Date: 2007
Publisher: Wiley-Blackwell
Publisher version: http://onlinelibrary.wiley.com/doi/10.1002/hep.21573/abstract
ISSN: 1527-3350
Citation: Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, et al. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 2007 Mar;45(3):602-613.
Abstract
Broad T cell and B cell responses to multiple HCV antigens are observed early in individuals who control or clear HCV infection. The prevailing hypothesis has been that similar immune responses induced by prophylactic immunization would reduce acute virus replication and protect exposed individuals from chronic infection. Here, we demonstrate that immunization of naïve chimpanzees with a multicomponent HCV vaccine induced robust HCV-specific immune responses, and that all vaccinees exposed to heterologous chimpanzee-adapted HCV 1b J4 significantly reduced viral RNA in serum by 84%, and in liver by 99% as compared to controls (P=0.024 and 0.028, respectively). However, despite control of HCV in plasma and liver in the acute period, in the chronic phase, 3 of 4 vaccinated animals developed persistent infection. Analysis of expression levels of proinflammatory cytokines in serial hepatic biopsies failed to reveal an association with vaccine outcome. However, expression of IDO, CTLA-4 [corrected] and PD-1 levels in liver correlated with clearance or chronicity. CONCLUSION: Despite early control of virus load, a virus-associated tolerogenic-like state can develop in certain individuals independent of vaccination history.
Permanent link: http://hdl.handle.net/10171/21727
Appears in Collections:DA - CIMA - Terapia génica y Hepatología - Inmunología clínica - Artículos de revista
DA - CUN - Medicina interna - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Virología - Artículos de revista
DA - Medicina - Medicina Interna - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista

Files in This Item:

There are no files associated with this item.

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.